Evergreen Nephrology’s Post

𝗔𝗕𝗢 𝗜𝗻𝗰𝗼𝗺𝗽𝗮𝘁𝗶𝗯𝗹𝗲 𝗧𝗿𝗮𝗻𝘀𝗽𝗹𝗮𝗻𝘁: 𝗪𝗵𝗮𝘁 𝗬𝗼𝘂 𝗡𝗲𝗲𝗱 𝘁𝗼 𝗞𝗻𝗼𝘄 | 𝗗𝗿. 𝗦𝗵𝗮𝘀𝗵𝗮𝗻𝗸 𝗦𝗵𝗲𝘁𝘁𝘆 | 𝗔𝘀𝘁𝗲𝗿 𝗖𝗠𝗜 𝗛𝗼𝘀𝗽𝗶𝘁𝗮𝗹 Join Dr. Shashank Shetty, Consultant in Nephrology at Aster CMI Hospital, as he explains the intricacies of ABO Incompatible Transplants. In this insightful video, Dr. Shetty discusses what ABO Incompatible Transplants are, the challenges involved, and the advancements that have made these transplants possible. Learn about the preparation process, risks, benefits, and success rates of these transplants. Gain a deeper understanding of how ABO Incompatible Transplants offer new hope to patients with kidney failure. Watch now for expert insights and valuable information! #ABOIncompatibleTransplant #Nephrology #AsterCMIHospital #KidneyTransplant #DrShashankShetty #TransplantAdvancements #KidneyHealth #HealthEducation #PatientCare #MedicalInnovation

📍 ASN Kidney Week 2024, San Diego If you're attending American Society of Nephrology Kidney Week 2024, please look out for Tom Shadrix, Vice President of Point of Care Testing Sales at Woodley Trial Solutions. Tom can give you a quick overview of how our equipment supply solutions can add value and efficiency to your nephrology study; and how POCT device utilization can significantly reduce your patient screen failure rates, and support patient diversity. To arrange a meeting with Tom simply send a DM to Tom Shadrix. #kidneywk #kidneyweek #kidneyweek2024 #asn #nephrology #clinicaltrials #clinicalresearch

New study shows extended hemodialysis (HD) may improve survival rates except for those aged 75+. In this insightful article by Matthew A. Roberts, MD, learn about the risks and benefits associated with extended HD, key subgroup findings, and the importance of individual patient considerations in treatment decisions. A must-read for nephrologists and healthcare professionals navigating dialysis care. #Hemodialysis #Nephrology #PatientCare #HealthcareResearch

Ever wondered why nocturnal home hemodialysis is often referred to as the “Gold Standard" of dialysis? In this Q&A, nephrologist Dr. Brigitte Schiller and Patient Advocate Erich Ditschman explore the transformative potential of nocturnal home hemodialysis. From improved fluid management and heart health to practical safety tips, they address the key questions and benefits that make this modality an often underutilized option for some patients. Dive into their discussion to discover how personalized, longer treatments can fit into a patient-centered approach while potentially enhancing quality of life. 📖 Read the full Q&A: https://bit.ly/4eXxBE9 #Nephrology #HomeHemodialysis #PatientCare #NxStageSystems

Renal biopsy: a small procedure with big insights! 🩺✨ As dialysis technologists, understanding the process helps us support diagnosis and treatment, ensuring the best care for our patients. Let's stay informed, vigilant, and collaborative to optimize outcomes in kidney health! #RenalBiopsy #DialysisTechnologist #KidneyCare #Nephrology #PatientCare #HealthcareProfessionals

https://lnkd.in/gapteJJG Article title: Illness Perception and Hopelessness in Hemodialysis Author(s): Mukadder Mollaoglu; Ferhan Candan; Muratcan Mollaoglu Journal: Archives of Clinical Nephrology Journal ISSN: 2581-3870 Abstract: Background: Illness perception is useful in understanding the impact of hopelessness on ESRD patients. This perception has been found to be an important determinant of behavior and has been associated with a number of important outcomes such as treatment adherence and functional recovery and quality of life. Aim: The aims of this study were to determine, the level of hopelessness and to evaluate whether illness perception is related to hopelessness among End-stage Renal Disease (ESRD) patients on hemodialysis (HD). #IllnessPerception #Hopelessness #HemodialysisPatients #DiabeticNephropathy #ChronicKidneyDiseases #AcuteKidneyDisease #KidneyFibrosis #KidneyCalculi #RenalFailure #RenalTransplantation #ChronicHaemodialysis #RenalCancer #RenalImpairment #Glomerulonephritis #Urogynecology #ReconstructiveUrology #RenalHypertension #Nephrolithiasis #RenalImmunology #RenalPhysiology #RenalOsteodystrophy #RenovascularDisease #Peertechz #PeertechzPublications #ClinicalNephrology #PediatricNephrology #Neurourology #PediatricUrology #TubulointerstitialDisorders #GeriatricNephrology #Haematuria

Thanks to the efforts of nephrology care teams, more patients are utilizing home dialysis. Healthcare providers are improving training to successfully educate and empower patients and their caregivers, thereby decreasing early mortality rates and home dialysis failures. Read more! https://go.nephu.org/OARu  #homedialysis #nephrology #patientempowerment

Nocturnal should be the one initially offered. What do most patients eventually end up doing doing dialysis????? SLEEP!! more dialysis no matter how you look at it is better for the body. That is why home hemo is better, longer more often dialysis is acting more like a kidney. For someone like my wife Christina, someone that may not ever get another kidney, we want and deserve the most effective dialysis to keep her healthy!!! LET ME SAY OT FOR THE ONES IN THE BACK!!! MORE OFTEN DIALYSIS IS JUST BETTER!! Biggest fear…. What if my needles come out??!! If being trained properly and checking those needles you should be able to pretty much yank on those lines without problem!!! BLIND CHICK Living - on dialysis, Michael Gilchrist, Christina Gilchrist We are not doctors, we are a Carepartner and a blind chick. Always check with your kidney team. #ChristinaGilchrist #BlindChickLiving #MichaelGilchrist #thecaretaker #carepartner #caregiver #LIVINGondialysis #NxStage #AtHomeWithNxStage #OnTheRoadwithNxStage #fresenius #HomeDialysis #DialysisAtHome #KidneyCommunity #HHD #DialysisStrong #KidneyCarePartner #KidneyWarrior #Dialysis #cannulation #cannulate #needle #notdead #living #medical #fistula #graft #cvc #carepartnerkidneydonor

NxStage Medical, Inc. has crafted a façade of advocacy that, in reality, is a meticulously engineered marketing strategy designed to manipulate trust, control narratives, and drive sales. Let’s call it what it is: corporate opportunism at the expense of vulnerable patients and the broader renal community. This isn’t just a questionable practice—it’s a betrayal. The core of NxStage’s problem lies in its deliberate lack of transparency. By aligning with carefully selected individuals labeled as “advocates” or “experts,” NxStage presents these voices as impartial, when they are deeply tied to the company’s agenda. These so-called advocates don’t speak for the community—they echo corporate priorities. Patients are misled into believing these endorsements are authentic, when in reality they’re strategic partnerships designed to funnel patients into the NxStage pipeline. Even more concerning is how NxStage oversimplifies the diverse and complex challenges faced by the renal community. Their marketing glosses over the harsh realities patients face—whether it’s financial hardship, logistical hurdles, or deeply personal choices. Instead of presenting solutions tailored to the diverse needs of patients, NxStage offers a one-size-fits-all narrative designed to drive revenue. This kind of blanket marketing not only misrepresents reality but actively harms patients by steering them away from options that might be better suited to their specific situations. NxStage’s actions raise serious ethical questions, and their disregard for transparency and patient autonomy needs to be called out. Advocacy isn’t about controlling narratives to serve corporate goals. NxStage’s approach, however, seems to be less about empowerment and more about persuasion. Here’s why their tactics are harmful and why they undermine trust across the board: 🛑 Concealing financial and strategic relationships 💬 Deploying biased “advocates” to push agendas 🪤 Exploiting the trust of vulnerable patients 🚪 Ignoring the individual complexities of patient care 💸 Prioritizing sales above patient needs ❌ Undermining independent, informed patient decisions This behavior is especially damaging to a community already burdened with complex health challenges. Dialysis patients and their families face enough hurdles—financial, emotional, logistical—without being subjected to manipulative marketing masquerading as advocacy. NxStage’s strategy doesn’t empower patients; it traps them in a cycle of controlled information designed to steer them toward the company’s products. What’s even more troubling is how NxStage’s tactics reflect a broader issue in the healthcare industry: the prioritization of corporate profits over patient well-being. By controlling the conversation, companies like NxStage strip patients of their autonomy, replacing authentic advocacy with hollow campaigns designed to protect their bottom line. NxStage, your approach isn’t just flawed—it’s harmful.

Done well, chronic care management helps you engage your patients in their care to drive better outcomes. Ishan Ghildyal explains some of the benefits nephrologists have seen with their #ESRD patients. #nephrology #endstagerenaldisease #dialysis #optimalstart #patientactivationmeasures